Cardio Diagnostics Holdings, Inc. (CDIO) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Cardio Diagnostics Holdings, Inc. (CDIO) closed at USD 1.67 on 2026-10-14, a change of -60.6 % over the past year, with a market capitalization of USD 5.21M.

Cardio Diagnostics Holdings, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Cardio Diagnostics Holdings, Inc. key figures

Previous close

USD 1.67 (2026-10-14)

1-year change

-60.6 %

Market cap

USD 5.21M

Enterprise value

USD -8,333

P/E ratio (trailing)

-0.63

P/E ratio (forward)

-7.04

EPS (trailing)

-2.78

EPS (forward)

-0.25

PEG ratio

n/a

Price to book

0.70

Revenue growth

-28.3 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.03

Employees

15

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Cardio Diagnostics Holdings, Inc.

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management. It also provides CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases; and HeartRisk, a SaaS cardiovascular disease risk intelligence platform. It serves telemedicine providers; provider organizations, such as concierge practices, longevity clinics, and risk-bearing provider organizations; and employer organizations. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Cardio Diagnostics Holdings, Inc. and compare it with other stocks.